小儿糖尿病合并支气管哮喘治疗研究  

Research on Treatment of Pediatric Diabetes and Bronchial Asthma

作　　者：翟静[1] 

机构地区：[1]长春市儿童医院呼吸一科,吉林长春130000

出　　处：《糖尿病新世界》2017年第2期56-57,共2页Diabetes New World Magazine

摘　　要：目的探讨小儿糖尿病合并支气管哮喘的治疗与效果。方法选取2014年6月—2016年6月该科收治的糖尿病合并支气管哮喘患儿156例,随机分为两组各78例,A组给予抗感染、支气管扩张剂等综合治疗,B组在A组的基础上给予糖皮质激素。结果 B组总有效率为92.3%,显著优于A组83.3%(P<0.05);B组喘息缓解时间(20.6±1.4)h、呼吸困难缓解时间(29.2±3.8)h、肺部哮鸣音缓解时间(3.7±0.6)d明显优于A组(P<0.05)。结论对患儿进行综合治疗,控制血糖,可有效缓解患儿临床症状,提高治疗效果。Objective To discuss the treatment effect of pediatric diabetes and bronchial asthma. Methods 156 cases of children with diabetes and bronchial asthma admitted and treated in our hospital from June 2014 to June 2016 were selected and randomly divided into two groups with 78 cases in each, the group A adopted the general treatment of anti-infection and bronchodilators, while the group B adopted the glucocorticoid on the basis of the group A. Results The total effective rate in the group B was obviously better than that in the group A(92.3% vs 83.3%),(P<0.05), the breather relief time, dyspnea relief time and lung wheezing rale in the group B were respectively(20.6±1.4)h,(29.2±3.8)h and(3.7±0.6)d, which were obviously better than those in the group A(P<0.05). Conclusion The general treatment of children and blood sugar control can effectively relieve the clinical symptoms and improve the treatment effect.

关 键 词：小儿糖尿病 支气管哮喘 治疗 

分 类 号：R587.1[医药卫生—内分泌]